[1]
A. Korga, “New tirapazamine derivatives protect cardiomyocytes from doxorubicin toxicity”, Curr. Issues Pharm. Med. Sci., vol. 33, no. 1, pp. 1–5, Mar. 2020, doi: 10.2478/cipms-2020-0001.